Daclizumab Subcutaneous and Novothyrox
Determining the interaction of Daclizumab Subcutaneous and Novothyrox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: levothyroxine
Brand name: Euthyrox, Levoxyl, Synthroid, Tirosint, Unithroid, Levothroid, Tirosint-Sol
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Noxafil
- Daclizumab Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- Daclizumab Subcutaneous-Noxafil (Posaconazole Injection)
- Daclizumab Subcutaneous-Noxafil (Posaconazole Oral Suspension)
- Daclizumab Subcutaneous-Noxafil Intravenous
- Daclizumab Subcutaneous-Noxifol-D
- Novothyrox-Dacogen
- Novothyrox-Dacomitinib
- Novothyrox-Dactinomycin
- Novothyrox-Dactinomycin Injection
- Novothyrox-Dactinomycin Intravenous
- Novothyrox-Daklinza